Trial Profile
Phase II Open Label Comparative Study of Cetuximab and Radiation Therapy Vs Surgery Before or After Radiation Therapy in Patients With Stage II to IV Colorectal Carcinoma.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms CC-ASI
- Sponsors Eli Lilly and Company
- 03 Feb 2010 Status changed from suspended to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 17 Dec 2009 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov.
- 18 Nov 2009 Planned end date changed from 1 Dec 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov.